[Boston, 4 June 2025] – Clearview Market Insights (CVMI) projects that the global antibody production market will grow from USD 18.1 billion in 2024 to USD 41.2 billion by 2031, achieving a robust compound annual growth rate (CAGR) of 12.6 percent. This expansion is driven by the increasing demand for monoclonal antibodies (mAbs), rapid biologics development pipelines, and ongoing innovation in cell-line engineering as well as continuous manufacturing.

“Antibodies have become foundational to modern medicine—from targeted cancer therapy to next-generation diagnostics,” said Dr. Ravi Chandra, lead biomanufacturing analyst at CVMI. “What was once a lab-scale tool has now matured into a multibillion-dollar industrial backbone supporting personalized healthcare, pandemic response, and global biosimilar growth.”

Request Sample @ https://clearviewmarketinsights.com/report-details/global-antibody-production-market/

Key Numbers

• 2024 Market Value: USD 18.1 billion
• 2031 Market Value: USD 41.2 billion
• Seven-Year CAGR: 12.6 percent
• Therapeutic Applications Share (2024): 53%
• North America Market Share: 38%

Market Drivers

• Rising Biologic Therapies
• Contract Manufacturing Demand
• Technological Advancements
• Global Health Preparedness
• Government Incentives

Company Highlights

• Lonza launched Ibex® Design, reducing the timelines for clinical-scale antibody production by 40 percent.
• Samsung Biologics has opened its fourth plant in Incheon, thereby doubling its antibody production capacity.
• WuXi Biologics commenced development of a mega-facility in Singapore with modular POD-based architecture.
• Thermo Fisher Scientific strengthened its biologics CDMO business through the acquisition of Belgium-based Henogen.

Regional Insights

• North America: Dominates the market with advanced CDMO infrastructure and high biologic drug consumption.
• Asia-Pacific: Fastest-growing region; China and India are scaling domestic production through government grants and tech transfers.
• Europe: Hosts a strong biosimilar manufacturing base.
• Latin America & MEA: Emerging interest in local antibody fill-finish and diagnostic assay development.

Technology Trends

• AI-driven Bioprocessing
• Modular Biomanufacturing
• Cell-Line Optimization
• Single-Use Systems

Milestones (2024–2025)

For more insights, visit https://clearviewmarketinsights.com/report-store  

About Clearview Market Insights

Clearview Market Insights is a global research and consulting firm that delivers forward-looking intelligence across more than 100 healthcare, biotechnology, and pharmaceutical markets. Our analysts synthesize real-time data, executive insights, and strategic models to support decision-making at the highest levels.

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369